RVMD icon

Revolution Medicines
RVMD

Overview Fund Activity

126 hedge funds and large institutions have $1.89B invested in Revolution Medicines in 2022 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 44 increasing their positions, 34 reducing their positions, and 7 closing their positions.

Holders
126
Holders Change
+9
Holders Change %
+7.69%
% of All Funds
1.99%
Holding in Top 10
9
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.14%
New
17
Increased
44
Reduced
34
Closed
7
Calls
$3.22M
Puts
$1.17M
Net Calls
+$2.05M
Net Calls Change
+$1.04M

Top Buyers

1
EC
1
EcoR1 Capital
California
$32.5M
2
T. Rowe Price Associates
2
T. Rowe Price Associates
Maryland
$58.7M
3
NI
3
Nextech Invest
Switzerland
$100M
4
FCM
4
Farallon Capital Management
California
$82.9M
5
Point72 Asset Management
5
Point72 Asset Management
Connecticut
$10M

Top Sellers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$73.1M
2
WP
2
Woodline Partners
California
$59.5M
3
CAM
3
Cormorant Asset Management
Massachusetts
$50.9M
4
Wellington Management Group
4
Wellington Management Group
Massachusetts
$104M
5
Citadel Advisors
5
Citadel Advisors
Florida
$1.7M
Name Holding Trade Value Shares
Change 		Shares
Change %
N
126
Natixis
France
– -$332K -13,200 Closed
FQ
127
First Quadrant
California
– -$269K -10,700 Closed
DTL
128
Dynamic Technology Lab
Singapore
– -$225K -8,944 Closed
PHK
129
Point72 Hong Kong
Hong Kong
– -$63K -2,485 Closed
2 3 4 5
6